Karyopharm Therapeutics Inc
F:25K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Karyopharm Therapeutics Inc
F:25K
|
US |
|
G
|
Glencore PLC
F:8GCA
|
CH |
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
N
|
NVIDIA Corp
F:NVD
|
US |
|
A
|
Amdocs Ltd
XMUN:AOS
|
US |
Intrinsic Value
The intrinsic value for
Karyopharm Therapeutics Inc (25K) under the Base Case is hidden
EUR.
Compared with the current market price of 4.7 EUR, the stock appears hidden
.
25K looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if 25K is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Karyopharm Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Karyopharm Therapeutics Inc
Earnings Waterfall
Karyopharm Therapeutics Inc
The intrinsic value for
Karyopharm Therapeutics Inc (25K) under the Base Case is hidden EUR.
Compared with the current market price of 4.7 EUR, the stock appears hidden.